Global child deaths reached historic low in 2022
On Mar. 12, 2024, the United Nations Inter-agency Group for Child Mortality Estimation (UN IGME) reported that the…
Penguins tested positive for Avian Flu on South Georgia
On Mar. 11, 2024, the British Antarctic Survey reported that penguins on the sub-Antarctic Islands of South Georgia…
Wegovy received FDA approval for cardiovascular risk reduction in adults with known heart disease or obesity
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
U.S. transitioning to trivalent flu vaccines for 2024-2025
On Mar. 8, 2024, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
FDA cleared first Over-the-Counter continuous glucose monitor
On Mar. 5, 2024, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) continuous…
Psittacosis reported in European region
On Mar. 5, 2024, the World Health Organization announced that In February 2024, Austria, Denmark, Germany, Sweden and…
Hugel Received FDA Approval in the U.S. of Letybo (letibotulinumtoxinA-wlbg) for Injection for Treatment of Glabellar Lines
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
New antibodies target ‘Dark Side’ of influenza virus protein
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
U.S. CDC Advisory Committee recommended use of Valnevaï¾’s single-dose Chikungunya caccine IXCHIQï¾®
On Feb. 29, 2024, Valneva announced that the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory Committee…
FDA and industry actions end sales of Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) used in U.S. food packaging
On Feb. 28, 2024, the U.S. Food and Drug Administration (FDA) announced that grease-proofing materials containing per- and…
CDC | COVID-19 | Life Science News | Therapeutics | Vaccine
CDC Advisory Committee recommended older adults able to receive additional dose of updated COVID-19 vaccine
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
Biotechnology | CDC | COVID-19 | Vaccine
Novavax’s protein-based non-mRNA COVID-19 vaccine available as additional dose for individuals aged 65 and older
On Feb. 28, 2024, the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory Committee on Immunization Practices…
California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Non-Profit Research | Therapeutics | Vaccine
First Tissue Bank May Help Solve Mystery of Long COVID Misery
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
Scientists developed a simple blood test to quickly diagnose sarcoidosis
On Feb. 22, 2024, a National Institutes of Health (NIH) research supported project announced development of a tool…
NIH launched research network to evaluate emerging cancer screening technologies
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
Fred Hutch to lead new federal Cancer Screening Research Network
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
USDA and University of Georgia broke ground on new agriculture research facility in Tifton, Georgia
On Feb. 21, 2024, the U.S. Department of Agriculture (USDA) and the University of Georgia (UGA) College of…
CPRIT approved almost $100 million in grants to advance the fight against cancer in Texas
On Feb. 21, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
COVID-19 | Life Science History | Measles | Vaccine | WHO
WHO reported more than half the world faces high measles risk
On Feb. 21, 2024, the World Health Organization reported that more than half the world’s countries will be…
USDA confirmed highly pathogenic avian influenza in backyard non-poultry flock in West Virginia
On Feb. 20, 2024, the U.S. Department of Agriculture (USDA) confirmed the presence of highly pathogenic avian influenza…
275 million new genetic variants identified in National Institutes of Health precision medicine data
On Feb. 19, 2024, the National Institutes of Health (NIH) announced that researchers had discovered more than 275…
FDA approved Xolair as first and only medicine for children and adults with one or more food allergies
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
Japan first in the world to approve Dupixentï¾® (dupilumab) for chronic spontaneous urticaria
On Feb. 16, 2024, Regeneron and Sanofi announced that the Ministry of Health, Labor and Welfare (MHLW) in…
U.S. Centers for Disease Control and Prevention warned of E. Coli outbreak linked to raw milk cheese
On Feb. 16, 2024, the U.S. Centers for Disease Control and Prevention announced that ten people infected with…
Australian government approved release of QUT-developed GM Cavendish QCAV-4
On Feb. 16, 2024, the Australian Government announced it had issued QUT a licence to commercially release QCAV-4,…
New biosecurity group aims to prevent biotech disasters
On Feb. 15, 2024, Biosecurity experts today launched a new international nonprofit designed to prevent modern biotechnology from…
FDA approved first medication to treat severe frostbite
On Feb. 14, 2024, the U.S. Food and Drug Administration approved Eicos Sciences’ Aurlumyn (iloprost) injection to treat…
COVID-19 vaccination and boosting during pregnancy protects infants for six months
On Feb. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID) reported study results that showed…
European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…